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ApoptosisSutherlandia frutescens (SF) is a traditional African medicinal aid employed for the treatment of various ailments
such as inﬂammation, pulmonary asthma and congestion. The present study was conducted to demonstrate the
differential cellular interaction of aqueous SF extracts in a breast adenocarcinoma epithelial cell line (MCF-7) and
a non-tumorigenic breast cell line (MCF-12A) by means of polarization-optical differential interference contrast
microscopy, crystal violet staining, lightmicroscopy andﬂow cytometry. Results showed that aqueous SF extracts
induced cell death inMCF-7 andMCF-12A via two types of cell death namely apoptosis and autophagy. Effects on
proliferation and cytotoxicity were investigated bymeans of crystal violet staining. The latter indicated that, at a
1/10 dilution, the tumorigenic MCF-7 cell line was more prominently affected when compared to the non-
tumorigenic MCF-12A cell line. Apoptosis induction was demonstrated by qualitative and quantitative light
microscopy and cell cycle progression studies, while autophagy induction was assessed by an increase in micro-
tubule-associated protein light chain 3 (LC3) levels (a speciﬁc marker of autophagy). The MCF-7 tumorigenic
cells, however, were more susceptible to these extracts when compared to the non-tumorigenic MCF-12A
cells. Data obtained contribute towards understanding the differential cellular interaction exerted by aqueous
SF extracts in tumorigenic versus non-tumorigenic breast cells. Results will enable researchers to further study
cell death mechanisms induced by these aqueous extracts and to identify active compounds for evaluation in
anticancer therapy and potential in vivo efﬁcacy.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Cancer impacts severely on economic and social development, and
thus on human lives. Breast cancer is a major health problem amongst
women in South Africa (Vorobiof et al., 2001). According to the
National Cancer Registry (2003) it is ranked as the most commonly
found cancer among all South African females with the exception of
black females where it is ranked as the second most frequently found
cancer (Vorobiof et al., 2001; Herbst, 2011). It is estimated that one in
six South Africanmen and one in seven South Africanwomenwill be di-
agnosed with cancer during their lives. For the past few decades, plant
products have been identiﬁed to be a valuable source of anticancer
drugs since the latter tend to have minimal side effects (Gonzales and
Valerio, 2006)., Dulbecco's Modiﬁed Eagle's
ted protein light chain 3; PBS,
ifferential interference contrast;
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y Elsevier B.V. All rights reserved.Sutherlandia frutescens (SF), commonly known as the cancer bush, is
a Southern African shrub that belongs to the Fabaceae family (Stander
et al., 2007). Studies using extracts of this plant have demonstrated
that SF possesses pharmacological properties such as antithrombotic
(Kee et al., 2008), antibacterial (Katerere and Eloff, 2005), antidiabetic
(MacKenzie et al., 2009) and antiproliferative activities (Tai et al.,
2004). Recent studies performed in our laboratory (Department of
Physiology, University of Pretoria, South Africa) and by other re-
searchers revealed that these extracts inhibit cell growth in cancer cell
lines namely the human breast adenocarcinoma cell line (MCF-7,
MDA-MB-468), human promyelocyte (HL60), human prostate cancer
cell line (DU-145) and esophageal cancer cell line (SNO) (Stander
et al., 2009; Tai et al., 2004; Steenkamp and Gouws, 2006; Skerman
et al., 2011).
Stander et al. (2009) revealed that exposure ofMCF-7 cells to an eth-
anol extract of SF for a period of 48 h yielded a 50% growth reduction. In
addition, the antiproliferative activity of the SF extract was established
to be time- and concentration-dependent. MCF-7 cells were found to
be more sensitive to ethanol SF extracts when compared to MCF-12A
cells, suggesting differential signal transduction exerted by this ethanol
extract (Stander et al., 2009). Similarly, a concentration dependent ef-
fect of SF extracts on human leukemia (Jurkat) and breast (MCF-7 and
MDA-MB-468) tumor cell lines was observed (Tai et al., 2004).
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properties, several questions still remain with regard to the bioactive
chemical compounds that are present in the extracts of SF which are
responsible for its anticancer effect (Shaik et al., 2010; Van Wyk,
2012). It has also been shown that extracts of SF contain diverse meta-
bolic characteristics between different geographical locations and fur-
thermore SF samples harvested at different periods at the same
location (Albrecht et al., 2012). Sampleswere categorized in the follow-
ing manner: A (Garden grown-A at GPS coordinates South 35° 51′
32.12′; East 18° 39′ 45.69′ with spontaneous appearance in 2010); B
(Garden grown-B at GPS coordinates South 35° 51′ 32.12′; East 18°
39′ 45.69′ with continuous growth in 2011) (Albrecht et al., 2012). In
an effort to gain a better understanding of the mechanism of action of
SF extracts, this study investigated differential in vitro effects of aqueous
SF extract A and extract B on a tumorigenic breast cancer cell line and a
non-tumorigenic cell line. Data from this study contribute to the
unraveling of the mechanism of action that these extracts exert on tu-
morigenic and non-tumorigenic cells.
2. Materials & methods
2.1. Cell lines
The MCF-7 human breast adenocarcinoma cell line was obtained
from Highveld Biological Pty. (Ltd.) (Sandringham, South Africa). The
MCF-12A non-tumorigenic epithelial cell line was a gift from Professor
Parker (Department of Medical Biochemistry, University of Cape
Town, Cape Town, South Africa).
2.2. Reagents
Dulbecco's Modiﬁed Eagle's Medium (DMEM), penicillin, strepto-
mycin, fungizone and trypsin were bought from Highveld Biological
(Pty.) Ltd. (Sandringham, South Africa). Ham's F12 medium, Trypan
blue, Bouin's ﬁxative, propidium iodide (PI), formaldehyde, methanol,
Triton-X100, bovine serum albumin (BSA) and RNase Awere purchasedFig. 1.1. Effects onmorphology is demonstrated using PlasDIC onMCF-7 cells. PlasDIC images of
extract A (C), 1/10 dilution of extract B (D), actinomycin D-treated (E) and tamoxifen-treated
density as features of apoptosis, including the presence of shrunken cells, hypercondensed chrfrom Sigma-Aldrich Co. (Clubview, South Africa). Fetal calf serum (FCS),
sterile cell plates, sterile syringes and ﬁlters were purchased from Sepa-
rations (Pty.) Ltd. (Randburg, Johannesburg, South Africa). Hematoxy-
lin, eosin, ethanol, Entellan® ﬁxative and xylol were purchased from
Merck (Munich, Germany). Rabbit polyclonal anti-LC3B conjugated to
DyLight 488was purchased from BIOCOMbiotech Pty. (Ltd.) (Clubview,
South Africa). All the required reagents of cell culture analytical grade
were purchased from Sigma (St. Louis, United States of America) unless
otherwise speciﬁed.
2.3. Plant extract preparation
The SF extract is a complex mixture of ﬂavonoids, triterpenes, sapo-
nins and plant steroids (Albrecht et al., 2012). Leaves and small twigs of
SF were obtained from Dr Carl Albrecht (Cancer Association of South
Africa). Samples were categorized in the following manner: A (Garden
grown-A at GPS coordinates South 35° 51′ 32.12′; East 18° 39′ 45.69′
with spontaneous appearance in 2010); B (Garden grown-B at GPS co-
ordinates South 35° 51′ 32.12′; East 18° 39′ 45.69′ with continuous
growth in 2011) (Albrecht et al., 2012). Half a gram (0.5 g) of samples
A and B was weighed respectively, autoclaved, mixed with 50 ml of
boiled distilled water and subsequently extracted over a period of
15 h at room temperature. After extraction, the supernatant was trans-
ferred to a 50 ml tube and centrifuged at 2500 rpm for 10 min to re-
move any debris. The supernatant was ﬁltered thrice with a 0.22 μm
ﬁlter to obtain a puriﬁed 0.01 g/ml stock solution (Stander et al.,
2009; Vorster et al., 2012).
2.4. Cell culture
Cells were propagated in DMEM supplemented with 10% heat
inactivated FCS and 100 U/ml penicillin G, 100 μg/ml streptomycin
and 250 μg/l fungizone at 37 °C in a humidiﬁed atmosphere containing
5% CO2 and left overnight for attachment. MCF-12A cells were cultured
in a medium containing a 1:1 mixture of DMEM and Ham's-F12 medi-
um, 20 ng/ml epidermal growth factor, 100 ng/ml cholera toxin,MCF-7 cells propagated in growthmedium (A), 1/10 dilution ofwater (B), 1/10 dilution of
(F) cells after 48 h. Cells treated with extract A & extract B displayed a compromised cell
omatin and apoptotic bodies (Fig. 1.1C & D).
Fig. 1.2. Effects on morphology is demonstrated using PlasDIC onMCF-12A cells. PlasDIC images of MCF-12A cells propagated in growth medium (A), 1/10 dilution of water (B), 1/10 di-
lution of extract A (C), 1/10 dilution of extract B (D), actinomycin-D-treated (E) and tamoxifen-treated (F) cells following 48 h of exposure. Cell density of extract A- and extract B-treated
cells was decreased (Fig. 1.2C & D). Characteristics of apoptosis (shrunken cells, apoptotic bodies) and of autophagy (vacuoles) were observed in actinomycin D- and tamoxifen-treated
cells, respectively (Fig. 1.2E & F).
Fig. 2. Crystal violet staining demonstrating effects on cell numbers. Crystal violet staining
was conducted to demonstrate the effects of SF extracts A and B on cell growth and cyto-
toxicity at a dilution series of 1/10, 1/20, 1/40, and 1/80 for 48 h at 37 °C. Vehicle-treated
controls consisting of 1/10 water in growth medium were also included. Cell growth is
expressed as a percentage of cells propagated in growthmedium. Both extracts decreased
cell growth signiﬁcantlywith extract A possessing slightly stronger antiproliferative activ-
ity. A dilution of 1/10 is optimal for both extracts since the tumorigenic cell line wasmore
affectedwhen compared to the non-tumorigenic breast cell line. An asterisk (*) indicates a
statistically signiﬁcant P-value of b0.05 when compared to cells propagated in growth
medium.
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heat inactivated FCS, 100 U/ml penicillin G, 100 μg/ml streptomycin
and fungizone (250 μg/l) at 37 °C in a humidiﬁed atmosphere contain-
ing 5% CO2 and left overnight for attachment. Cells propagated in a
growth medium, cells treated with the same volume of distilled water
used to expose cells with 1/10 dilution of extract A and extract B respec-
tively (v/v), as well as positive controls for apoptosis (0.1 μg/ml actino-
mycin D) and autophagy (tamoxifen (20 μM)) were included for each
experiment as controls. A 1/10 dilution of extract A and extract B and
an exposure period of 48 h were selected. These parameters were cho-
sen based on our cell proliferation studieswhere at this time anddosage
extracts signiﬁcantly decreased cell proliferation of both cell lines, with
the tumorigenicMCF-7 cells beingmore affectedwhen compared to the
non-tumorigenic MCF12A cells.
2.5. Polarization-optical differential interference contrast
Polarization-optical differential interference contrast (PlasDIC) is a
polarization-optical transmitted light differential interference contrast
method. Unlike conventional DIC, linearly polarized light is only gener-
ated after the objective (Wehner, 2003). PlasDIC allows for high quality
imaging of cells and detection of morphological characteristics for apo-
ptosis and autophagy. Cells were seeded at 500000 cells per well in
6-well plates. After a 24 h incubation period at 37 °C to allow for cell ad-
herence, cells were exposed to extracts A and B respectively including
appropriate controls as previously described. Evaluationwas conducted
with a Zeiss inverted Axiovert CFL40 microscope equipped with a
PlasDIC ﬁlter and photomicrographs were taken with a Zeiss Axiovert
MRmmonochrome camera (Carl Zeiss MicroImaging, Inc., NY, USA).
2.6. Crystal violet staining
Crystal violet is a method used to determine the number of cells by
staining the deoxyribonucleic acid (DNA). Crystal violet staining allows
for the quantiﬁcation of cell numbers in monolayer cultures as a func-
tion of the absorbance of the dye taken up by the cells (Gillies et al.,
1986). Exponentially growing cells were seeded in 96-well tissue cul-
ture plates at a cell density of 5000 cells per well. Cells were incubated
at 37 °C in a humidiﬁed atmosphere containing 5% CO2 for 24 h toallow for attachment. Subsequently, the medium was discarded and
cells were exposed to the both SF extracts at a dilution series of 1/10,
1/20, 1/40, and 1/80 for 48 h at 37 °C. Vehicle-treated controls
consisting of 1/10 water in growth medium were also included. Cells
were ﬁxed with 100 μl of 1% gluteraldehyde (incubation for 15 min at
room temperature). Subsequently the gluteraldehyde was discarded
and cells were stained using 100 μl 0.1% crystal violet (incubated at
room temperature for 30 min). Thereafter the crystal violet solution
was discarded and the 96-well plate was submersed under running
water. Crystal violet was solubilized using 200 μl 0.2% Triton X-100
and incubated at room temperature for 30 min. Solution (100 μl) was
transferred to a new microtiter plate. Afterwards, the absorbance was
determined at 570 nm using an ELx800 Universal Microplate Reader
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America).2.7. Hematoxylin and eosin staining
Hematoxylin and eosin staining is a recognized method to demon-
strate the morphological effects of compounds on the cell nucleus and
cytoplasm and is used to visualize hallmarks of apoptosis (Van Zijl
et al., 2008; Stander et al., 2007). Hematoxylin and eosin staining was
conducted to observe the morphology of MCF-7 and MCF-12A cells
after 48 h of exposure to extract A and extract B. Exponentially growing
cells were seeded on heat-sterilized coverslips in 6-well plates at a den-
sity of 250000 cells per well and allowed to attach overnight. Cells were
then exposed to 1/10 dilution of extract A and extract B and appropriate
controls respectively for 48 h. After incubation, cells were ﬁxed with
Bouin's ﬁxative for 30 min. The ﬁxative was discarded and 70% ethanol
was added to the coverslips (20 min), rinsed in tap water and subse-
quently left for 20 min in Mayer's Hemalum. After rinsing with running
tap water for 2 min, coverslips were washed with 70% ethanol before
being subjected to 1% eosin for 2 min. This was followed by rinsing
twice for 5 min with 70% ethanol, 96% ethanol, 100% ethanol and
xylol, respectively. Coverslips were then mounted with resin and left
to dry before they were analyzed with a Zeiss Axiovert MRcmicroscope
(Zeiss, Göttingen, Germany) to obtain qualitative data. Photos were
taken utilizing a Zeiss Axiovert MRc microscope (Zeiss, Oberkochen,
Germany). In addition, hematoxylin- and eosin-stained samples were
used to determinemitotic indices. Quantitative data for themitotic indi-
ces was acquired by counting 1000 cells on each slide of the biological
replicates and expressing the data as the percentage of cells in each
phase of mitosis (prophase, metaphase, anaphase and telophase), cells
in interphase, cells demonstrating hallmarks of apoptosis and cells
displaying any abnormal morphology not associated with apoptosis
(Van Zijl et al., 2008). This hematoxylin and eosin staining yielded
both qualitative and quantitative information.Fig. 3.1. Light microscopymicrographs of hematoxylin & eosin stained MCF-7 cells. Hematoxyli
(B), 1/10 dilution of extract A (C), and 1/10 dilution of extract B (D) following 48 h of exposur
bodies was observed.2.8. Flow cytometry — cell cycle progression
Flow cytometry using PI staining allows for quantiﬁcation of cell
cycle progression and the presence of apoptosis indicated by the exis-
tence of a sub-G1 phase. Cells were seeded at 500000 cells per 25 cm2
ﬂasks and were incubated for 24 h to allow for attachment. Cells were
subsequently exposed to 1/10 dilution of extract A and extract B respec-
tively. Controls for both apoptosis and autophagy were included as pre-
viously described. After 48 h of incubation, cells were trypsinized and
resuspended in 1 ml of growth medium and samples were centrifuged
for 5 min at 300 ×g. Supernatant was discarded and cells were resus-
pended in 200 μl of ice-cold phosphate buffered saline (PBS) containing
0.1% FCS. In order to avoid cell clumping, 4 ml of ice-cold 70% ethanol
was added in a dropwisemanner while vortexing. Samples were stored
at 4 °C for 6 days and centrifuged at 300 ×g for 5 min. Supernatant
was removed and cells were resuspended in 1 ml of PBS containing
40 μg/ml PI and 100 μg/ml RNase A. The solution was incubated for
45 min in an incubator (5%CO2, 37 °C). Fluorescence of PI (measuring rel-
ative DNA content per cell) was determinedwith a ﬂuorescence activated
cell sorting (FACS) FC500 Systemﬂowcytometer (BeckmanCoulter South
Africa (Pty.) Ltd.) equipped with an air-cooled argon laser excited at
488 nm. Data fromno less than 30000 cells were analyzedwith CXP soft-
ware (Beckman Coulter South Africa (Pty.) Ltd.). Cell cycle distributions
were calculated with Cyﬂogic 1.2.1 (Perttu Terho & Cyﬂo Ltd., Finland)
by assigning relative DNA content per cell to sub-G1, G1, S and G2/M
fractions. Data obtained from the ﬂuorescence channel for redmonomers
(FL3 Lin) are shown as histograms on the x-axis.
2.9. Flow cytometry — autophagy detection: anti-LC3B staining
Autophagy is a form of programmed cell death where cytoplasmic
materials are degraded through lysosomal machinery. The microtubule-
associated protein light chain 3 (LC3) is a soluble protein and used as a
speciﬁcmarker tomonitor occurrence of this type of cell death. LC3 exists
in two forms, LC3-I and its proteolytic derivative LC3-II. LC3-I is found inn & eosin images of MCF-7 cells propagated in growth medium (A), 1/10 dilution of water
e. Cell density was compromised and the presence of cell protrusions, as well as apoptotic
Fig. 3.2. Light microscopy micrographs of hematoxylin & eosin stainedMCF-12A cells. Hematoxylin & eosin images of MCF-12A cells propagated in growth medium (A), 1/10 dilution of
water (B), 1/10 dilution of extract A (C), and 1/10 dilution of extract B (D) following 48 h of exposure. Extract A- and extract B-treated cells displayed compromised cell density and
shrunken cells (Fig. 2.2 C & D).
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autophagy stimulates the conversion of LC3-I to LC3-II and the upregula-
tion of LC3 expression. Identiﬁcation of LC3 II by immunoﬂuorescence is a
method that iswidely used formonitoring autophagy (Mizushima, 2004).
The LC3 antibody detection method was utilized to determine whether
extracts A & B induce autophagy in MCF-7 and in MCF-12A cells.
Cells were seeded at 500000 cells per 25 cm2 ﬂask. After 24 h of at-
tachment, the mediumwas discarded and cells were exposed to extract
A and extract B and to appropriate controls as previously deﬁned. After
incubation, cells were trypsinized and washed with ice-cold PBS. Cells
were ﬁxed with 0.01% formaldehyde in PBS for 10 min, pelleted andFig. 3.3.Mitotic indices ofMCF-7 cells.Mitotic indices ofMCF-7 cells propagated in growth
medium, 1/10 water dilution in growth medium and exposed to extract A and extract B.
Mitotic indices revealed a slight increase of cells present in apoptosis as demonstrated
by hallmarks of apoptosis after exposure to both extracts for 48 h (e.g. apoptotic bodies,
cell membrane blebbing and shrunken cells).then resuspended in 200 μl PBS. To permeabilize the cells, 1 ml of ice-
cold methanol (−20 °C) was added to the solution in a dropwise man-
ner. Cells were pelleted and washed twice with ice-cold PBS. After
washing, cells were pelleted, 0.5 ml of the primary antibody cocktail
was added and samples were incubated for 2 h at 4 °C in the dark.
Following 2 h of incubation, cells were washed trice with a wash buffer
(PBS/0.05% Triton/1%BSA) and analyzed with CXP software (Beckman
Coulter South Africa (Pty.) Ltd.). Data was analyzed using Cyﬂogic
1.2.1 software; data from ﬂuorescence channel for green monomers
(FL1 Log) was represented as histogram on the x-axis.Fig. 3.4. Mitotic indices of MCF-12A cells. Mitotic indices of MCF-A cells propagated in
growthmedium, 1/10 water dilution in growthmedium and exposed to extract A and ex-
tract B. Mitotic indices revealed a slight increase of cells present in apoptosis as demon-
strated by hallmarks of apoptosis after exposure to both extracts for 48 h (e.g. apoptotic
bodies, cell membrane blebbing and shrunken cells).
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Qualitative data were provided by PlasDIC images and hematoxylin
stained images. Data obtained from independent experiments are
shown as the mean ± S.D. Means are presented in bar charts, with
T-bars referring to standard deviations. All experimentswere conducted
in triplicate. Quantitative data for the mitotic indices was acquired by
counting 1000 cells on each slide of the biological replicates and ex-
pressing the data as the percentage of cells in each phase of mitosis
(prophase, metaphase, anaphase and telophase), cells in interphase,
cells demonstrating hallmarks of apoptosis and cells displaying any ab-
normal morphology not associated with apoptosis. In addition, further
quantitative data were obtained via cell cycle progression analysis and
autophagy detection analysis (anti-LC3B) assays. For ﬂow cytometric
data no less than 30000 events were counted for each sample. Flow cy-
tometric data produced was analyzed using Cyﬂogic 1.2.1 (Perttu Terho
& Cyﬂo Ltd., Finland).Fig. 4.1. Cell cycle progression of MCF-7 cells. Cell cycle distribution histograms of MCF-7 ce
A-treated (C), and 1/10 dilution of extract B-treated (D), actinomycin D-treated (E), and tamo
phase was observed in extract A-treated and in actinomycin D-treated cells indicating inductio4. Results
4.1. Polarization-optical differential interference contrast
PlasDIC indicated a decrease in the density of MCF-7 (Fig. 1.1) and
MCF-12A (Fig. 1.2) cells treatedwith extract A and extract B respective-
ly after 48 hwhen compared to cells propagated in growthmediumand
to vehicle-treated cells. Qualitative images of extract A revealed a more
pronounced antiproliferative effect when compared to extract B after
48 h of exposure.
4.2. Crystal violet staining
Dose-dependent studies were conducted with the purpose of evalu-
ating the antiproliferative effects of extract A and extract B on tumori-
genic breast epithelial and non-tumorigenic breast cell lines (Fig. 2).
Statistical signiﬁcant antiproliferative activity was demonstrated usinglls propagated in growth medium (A), vehicle-treated cells (B), 1/10 dilution of extract
xifen-treated (F) cells after 48 h of exposure. An increase in the number of cells in sub-G1
n of apoptosis.
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Extract B also exerted antiproliferative activity at all doses. However,
both extracts possessed optimal antiproliferative activity at 1/10 dilu-
tion. However, the latter dilution affected the tumorigenic cell line
more prominently.4.3. Hematoxylin & eosin staining
Hematoxylin & eosin staining of extract A and extract B exposure to
MCF-7 (Fig. 3.1) and MCF-12A (Fig. 3.2) cells were performed to investi-
gate in vitro effects on morphology. Extract A and extract B exposures
resulted in compromised cell density in both cell lines after 48 h when
compared to vehicle-treated cells. Furthermore, the MCF-7 tumori-
genic cells were pronouncedly affected when compared to the non-
tumorigenic MCF-12A cells. Mitotic indices (Figs. 3.3 and 3.4) revealed a
slight increase of cells present in apoptosis as demonstrated by hallmarksFig. 4.2. Cell cycle progression of MCF-12A cells. Cell cycle distribution histograms of MCF-12A
A-treated (C), 1/10 dilution of extract B-treated (D), actinomycinD-treated (E), and tamoxifen-t
apoptotic inﬂuence of extracts A and B respectively when compared to the tumorigenic MCF-7of apoptosis after exposure to both extracts for 48 h (e.g. apoptotic bodies,
cell membrane blebbing and shrunken cells).
4.4. Flow cytometry — cell cycle progression
To provide quantitative data in addition to the qualitative data sup-
plied above, ﬂow cytometry was used to analyze the effects of on cell
cycle progression. MCF-7 cells showed an increase in the number of ex-
tract A-treated (1/10 dilution) (20.59%) cells in sub-G1 phase indicative
of apoptosis when compared to extract B-treated (2.02%) cells and
vehicle-treated cells present in sub-G1 (0.57%) (Figs. 4.1 and 4.2). Flow
cytometry results suggest that extract A statistically signiﬁcantly
(P b 0.005) inhibits growth of MCF-7 cells in vitro via apoptosis. Extract
A- (4.9%) and extract-B-treated (1.6%) MCF-12A cells demonstrated a
statistically insigniﬁcant increase in the number of cells in sub-G1
phase respectively when compared to vehicle-treated cells (3.5%) pres-
ent in sub-G1 (Tables 1 and 2).cells propagated in growth medium (A), vehicle-treated cells (B), 1/10 dilution of extract
reated (F) cells after 48 h. The non-tumorigenicMCF-12A cells were less susceptible to the
cells.
Table 1
Percentage ofMCF-7 cells in sub-G1, G1, S andG2/M phases as determined by Cyﬂogic 1.2.1
(Perttu Terho & Cyﬂo Ltd.).
Phase Growth
medium
Water
1/10D
Extract A Extract B Actinomycin D Tamoxifen
Sub-G1 0.57 0.19 20.59 2.02 30.31 2.21
G1 62.73 55.35 45.5 54.18 30.87 58.54
S 15.67 17.07 14.4 16.19 19.93 17.06
G2/M 20.97 27.17 18.66 24.2 18.43 21.69
Fig. 5.1. Autophagy induction inMCF-7 cells. Histogram of mean ﬂuorescence intensity of
MCF-7 cells treated with 1/10 dilution of extract A (green histogram), 1/10 dilution of ex-
tract B (pink histogram) and tamoxifen (red histogram) overlaid on cells propagated in
growth medium (blue histogram) following 48 h of exposure (A). An increase in LC3
levels (shown by a shift to the right) was observed in MCF-7 cells treated with extract A
and extract B when compared to the control-treated cells.
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Autophagy induction by extract A and extract B in MCF-7 and MCF-
12A cellswas evaluated bymeans of a conjugated rabbit polyclonal anti-
LC3B antibody assay (Figs. 5.1 and 5.2). As previously mentioned, LC3 is
a soluble protein used as a speciﬁcmarker to demonstrate the induction
of autophagy. LC3-I is found in the cytoplasm whereas LC3-II binds to
autophagosomes. The induction of autophagy stimulates the conversion
of LC3-I to LC3-II and the upregulation of LC3 expression. Thus, LC3 II is a
useful indicator when investigating the presence of autophagy. Accord-
ing to the supplier's manual, an increase in mean ﬂuorescence intensity
(shift to the right) indicates an increase in the protein levels of LC3.
MCF-7 cells treated with both extract A and extract B showed an in-
crease in ﬂuorescence when compared to cells propagated in growth
medium. MCF-12A cells treated with extract A and extract B showed a
statistically insigniﬁcant increase in LC3 levels when compared to con-
trol. Results indicate that the tumorigenic MCF-7 cells are more suscep-
tible to the treatment of extract A and extract B when compared to the
non-tumorigenic MCF-12A cells.
5. Discussion
In this study the in vitro differential cellular interaction of aqueous
SF extract A and extract B (Albrecht et al., 2012) was investigated on a
breast adenocarcinoma cell line (MCF-7) and a non-tumorigenic breast
cell line (MCF-12A). Morphological studies conducted by means of
PlasDIC and light microscopy revealed characteristics associated with
apoptosis induction including shrunken cells, hypercondensed chroma-
tin and the presence of apoptotic bodies. Reduced cell density was ob-
served in both MCF-7 and MCF-12A cells, with the tumorigenic MCF-7
cell line being more affected. Similarly, Stander et al. (2007) found
that there was a signiﬁcant increase in the number of hypercondensed
shrunken in MCF-7 cells and apoptotic bodies after treatment with an
ethanol extract of SF. Apoptotic cellswere observed in SF-treated esoph-
ageal cancer cell line (SNO), Chinese hamster ovary (CHO) cell line as
well as in human mammary adenocarcinoma (MDA-MB-468) cell line
(Skerman et al., 2011; Chinkwo, 2005; Tai et al., 2004).
To further investigate the differential interaction on cell cycle pro-
gression of extract A and extract B onMCF-7 andMCF-12A cells,ﬂow cy-
tometry studies were conducted. Treatment of MCF-7 cells with extract
A and extract B caused an increase in the sub-G1 fractionwhich is indic-
ative of apoptosis induction. Results were consistent with those of our
previously reported data (Stander et al. (2009)). An increase in the
sub-G1 fraction for extract A- (4.9%) and extract B-treated (1.6%) sam-
ples were observed. This increase in the sub-G1 fraction was more
pronounced when compared to cells propagated in growth mediumTable 2
Percentage of MCF-12A cells in sub-G1, G1, S and G2/M phases as determined by Cyﬂogic
1.2.1 (Perttu Terho & Cyﬂo Ltd., Finland).
Phase Growth
medium
Water
1/10D
Extract A Extract B Actinomycin D Tamoxifen
Sub-G1 0.14 3.51 4.9 1.6 56.35 15.16
G1 43.75 41.72 58.27 68.13 14.28 49.62
S 20.24 21.44 13.63 12.33 12.71 13.9
G2/M 35.41 31.95 22.48 17.88 6.16 19.35(0.14%). Extract A- and extract B-treated MCF-12A cells demonstrated
a statistically insigniﬁcant increase in the number of cells in sub-G1
phase respectively when compared to vehicle-treated cells (3.5%). To
further substantiate induction of apoptosis, morphological changes
were investigated to obtain both qualitative and quantitative data to
prove the presence of apoptosis (Van Zijl et al., 2008).Mitotic indices re-
vealed a slight increase of cells present in apoptosis as demonstrated by
hallmarks of apoptosis after exposure to both extracts for 48 h (e.g. ap-
optotic bodies, cell membrane blebbing and shrunken cells).
Additionally it was shown that SF extracts induce another type of
cell death together with apoptosis known as autophagy. Autophagy is
amechanismof survival for cells during periods of stress and starvation,
but it has been observed that there are times where autophagy can
progress to cell death (Tsujimoto and Shimizu, 2005). Studies revealed
an increase in LC3 levels in MCF-7 cells treated with extract A and ex-
tract B was observed when compared to cell propagated in growth me-
dium. Again, the non-tumorigenic MCF-12A cells treated with extract A
and extract B respectively did not show a statistically signiﬁcant in-
crease in LC3 levels when compared to the control.
The occurrence of both apoptosis and autophagy implies existence of
crosstalk among these two types of cell deaths induced by aqueous SF
extracts A and B (Vorster et al., 2012; Azad et al., 2009). This in vitro
study revealed that both extract A and extract B induce apoptosis and
autophagy in the tumorigenic MCF-7 cells leaving non-tumorigenic
MCF-12A cells less affected. Our data also conﬁrms the importance of
sample collection at speciﬁc time intervals. Results from this study dem-
onstrated that the speciﬁc time period when harvesting takes placeFig. 5.2. Autophagy induction inMCF-12A cells. Histogram ofmean ﬂuorescence intensity
ofMCF-12A cells treatedwith 1/10dilution of extract A (green histogram), 1/10 dilution of
extract B (pink histogram) and tamoxifen (red histogram) overlaid on the vehicle-treated
cells (blue histogram) following 48 h of exposure (B). Results demonstrated no signiﬁcant
increase in LC3 levels of MCF-12A cells treated with extract A and extract B when com-
pared to control-treated cells.
67T.V. Mqoco et al. / South African Journal of Botany 90 (2014) 59–67inﬂuences the extract's antiproliferative potential. These extracts may
have signiﬁcantly different chemical constituents and therefore exert
differential mechanisms of action in the molecular crosstalk between
apoptosis and autophagy. Future studies on effects of various proposed
bioactive chemical compounds of the extracts on tumorigenic and non-
tumorigenic cells are warranted to further understand the mechanism
of action of SF and the potential in vivo efﬁciency as a cancer treatment.Acknowledgments
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